Tom Fitzgerald

Tom Fitzgerald has a diverse work experience in finance and business operations. Tom started their career in 1996 at Leerink Swann & Company, where they founded and managed the investment banking and syndicate departments. Tom provided financial advisory services to emerging growth companies in the life sciences industry.

In 2001, Fitzgerald joined Lavipharm Laboratories Inc. as the Senior VP and CFO, overseeing financial leadership for the international pharmaceutical company. Tom managed a staff of eight and achieved peak revenues of approximately $22 million.

From 2004 to 2006, Fitzgerald served as the inaugural CFO for The Saint Consulting Group, a consulting firm with $25 million in annualized revenues and 11 offices in the U.S.

In 2006, Fitzgerald became the CFO of Velico Medical, Inc., a pre-revenue medtech company. Tom successfully led the company through a rescue and turnaround effort, raising capital and implementing/upgrading reporting systems. Tom also prepared the company for an IPO or other liquidity event.

Starting in 2018, Fitzgerald took on the role of Managing Director at Boston Financial, LLC. Tom served as a CFO and raised capital for entrepreneurial companies, with a focus on the life sciences sector. Tom also oversaw senior operations roles, including IT, HR, Legal, and Facilities.

In the same year, Fitzgerald became the CFO and Director of TransCode Therapeutics, Inc. Tom managed financial and business operations for the pre-clinical RNA company and successfully led them through an IPO in July 2021.

Overall, Fitzgerald's work experience showcases their expertise in financial management, capital raising, turnaround efforts, and strategic development in various industries, particularly in the life sciences sector.

Tom Fitzgerald has a degree in Economics from Stanford University (AB). Tom also has an MBA from Harvard Business School. However, no specific start or end years are provided for either of these educational experiences.